PTEN loss confers resistance to anti-PD-1 therapy in NSCLC by increasing tumor infiltration of T regulatory cells

被引：3
|
作者：
Exposito, Francisco
Redrado, Miriam
Houry, Maeva
Hastings, Katherine
Molero-Abraham, Magdalena
Lozano, Teresa
Solorzano, Jose L.
Ortega, Julian Sanz
Andradas, Vera
Amat, Ramon
Redin, Esther
Leon, Sergio
Legarra, Naroa
Garcia, Javier
Serrano, Diego
Valencia, Karmele
Robles-Oteiza, Camila
Foggetti, Giorgia
Felip, Enriqueta
Lasarte, Juan J.
Paz-Ares, Luis
Zugazagoitia, Jon
Politi, Katerina
Montuenga, Luis M.
Calvo, Alfonso
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-1124
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1124
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Dynamic alteration of peripheral immune cells in patients with NSCLC received anti-PD-1 therapy and clinical efficacy
    Yoshimura, Naruo
    Kaifu, Toshinori
    Takeda, Kazuya
    Atobe, Yuri
    Sasaki, Takanobu
    Sugawara, Takafumi
    Tabata, Toshiharu
    Ohrui, Takashi
    Nakamura, Akira
    ANNALS OF ONCOLOGY, 2021, 32 : S344 - S344
  • [42] Anti-PD-1 antibody armored γδ T cells enhance anti-tumor efficacy in ovarian cancer
    Yue Wang
    Jingyi Han
    Dongdong Wang
    Menghua Cai
    Yi Xu
    Yu Hu
    Hui Chen
    Wei He
    Jianmin Zhang
    Signal Transduction and Targeted Therapy, 8
  • [43] The IFN-γ/PD-L1 axis between T cells and tumor microenvironment: hints for glioma anti-PD-1/PD-L1 therapy
    Qian, Jiawen
    Wang, Chen
    Wang, Bo
    Yang, Jiao
    Wang, Yuedi
    Luo, Feifei
    Xu, Junying
    Zhao, Chujun
    Liu, Ronghua
    Chu, Yiwei
    JOURNAL OF NEUROINFLAMMATION, 2018, 15
  • [44] Anti-PD-1 antibody armored γδ T cells enhance anti-tumor efficacy in ovarian cancer
    Wang, Yue
    Han, Jingyi
    Wang, Dongdong
    Cai, Menghua
    Xu, Yi
    Hu, Yu
    Chen, Hui
    He, Wei
    Zhang, Jianmin
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2023, 8 (01)
  • [45] The IFN-γ/PD-L1 axis between T cells and tumor microenvironment: hints for glioma anti-PD-1/PD-L1 therapy
    Jiawen Qian
    Chen Wang
    Bo Wang
    Jiao Yang
    Yuedi Wang
    Feifei Luo
    Junying Xu
    Chujun Zhao
    Ronghua Liu
    Yiwei Chu
    Journal of Neuroinflammation, 15
  • [46] Radiation Plus Anti-PD-1 Therapy for NSCLC Brain Metastases: A Retrospective Study
    Liao, Guixiang
    Qian, Yuting
    Arooj, Sumbal
    Zhao, Zhihong
    Yan, Maosheng
    Li, Zihuang
    Yang, Hongli
    Zheng, Tao
    Li, Gang
    Li, Xianming
    Khan, Muhammad
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [47] Multimodal therapy with a potent vaccine, metronomic cyclophosphamide and anti-PD-1 enhances immunotherapy of advanced tumors by increasing activation and clonal expansion of tumor infiltrating T cells
    Weir, Genevieve
    Hrytsenko, Olga
    Quinton, Tam
    Karkada, Mohan
    Berinstein, Neil L.
    Stanford, Marianne
    Mansour, Marc
    CANCER RESEARCH, 2016, 76
  • [48] Imaging of Activated T Cells as an Early Predictor of Immune Response to Anti-PD-1 Therapy
    Levi, Jelena
    Lam, Tina
    Goth, Samuel R.
    Yaghoubi, Shahriar
    Bates, Jennifer
    Ren, Gang
    Jivan, Salma
    Huynh, Tony L.
    Blecha, Joseph E.
    Khattri, Roli
    Schmidt, Karl F.
    Jennings, Dominique
    VanBrocklin, Henry
    CANCER RESEARCH, 2019, 79 (13) : 3455 - 3465
  • [49] Anti-PD-1 therapy can possibly reverse CAR T cells exhaustion in DLBCL
    Lamure, Sylvain
    Herbaux, Charles
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 202 (02) : 217 - 218
  • [50] Tumor intrinsic CDC42BPB confers resistance to anti-PD-1 immune checkpoint blockade in breast cancer
    Deshpande, Ravindra Pramod
    Wu, Kerui
    Wu, Shih-Ying
    Tyagi, Abhishek
    Hunting, John
    Ruiz, Jimmy
    Li, Wencheng
    Watabe, Kounosuke
    CANCER RESEARCH, 2023, 84 (06)
12345